1. The adrenergic amines noradrenaline and adrenaline increased flux through phenylalanine hydroxylase by approx. 50%. 2. This effect, which appears to be mediated by an a-adrenergic mechanism, was accompanied by a rapid increase in the phosphorylation of phenylalanine hydroxylase. 3. Although ionophore A23187 mimicked the effects of the adrenergic amines, vasopressin was completely without effect on either phenylalanine hydroxylation or enzyme phosphorylation. 4. Flux through phenylalanine hydroxylase in young rats (80g) was insensitive to aadrenergic, but sensitive to P-adrenergic, agents. 5. Consistent with previous observations [Fisher & Pogson (1984) Biochem. J. 219, [79] [80] [81] [82] [83] [84] [85] the present data indicate a close correlation between phosphorylation state and flux rate (i.e. enzyme activity).
Phenylalanine hydroxylase [L-phenylalanine, tetrahydropteridine oxygen oxidoreductase (4-hydroxylating); EC 1.14.16.1] catalyses the first, and physiologically irreversible, step in phenylalanine catabolism:
L-Phenylalanine + tetrahydrobiopterin + 02 L-tyrosine + dihydrobiopterin + H20 Enzyme activity is controlled in the short term by a phosphorylation-dephosphorylation cycle (Abita et al., 1976; Donlon & Kaufman, 1980) , and in the longer term by changes in total enzyme activity, presumably reflecting altered protein concentration (Carr & Pogson, 1981; Donlon & Beirne, 1982) .
Phosphorylation by the cyclic AMP-dependent protein kinase is well characterized for the purified protein (Abita et al., 1976) , in vivo (Donlon & Kaufman, 1978) , and in isolated liver cells (Fisher & Pogson, 1984 (Garrison, 1978; Garrison et al., 1979; Garrison & Wagner, 1982; Garrison, 1983) . Another possibility, raised by Bublitz (1971) , is that adrenaline may act directly and reversibly to inhibit phenylalanine hydroxylase itself (Miller & Shiman, 1976) .
More recent work has provided indications that vasopressin may act by a cyclic AMP-independent mechanism distinct from that for a-adrenergic effectors. Thus fatty acid synthesis is stimulated by vasopressin, but not by phenylephrine (Assimacopoulos-Jeannet et al., 1981) ; there are also differences in the way in which vasopressin and aadrenergic amines regulate gluconeogenesis (Kneer & Lardy, 1983) . Additionally, hepatic protein-phosphorylation patterns are not identical for the two agents (Garrison, 1983) .
The studies described in the present paper were undertaken in order to clarify the responsiveness of phenylalanine hydroxylase to a range of hormonal stimuli. Simultaneous measurements of flux through the hydroxylase in cells confirm that phosphorylation is associated with changes in catalytic activity under physiologically relevant conditions.
Materials and methods Animals
Male Sprague-Dawley rats (University of Manchester breeding colony) were used throughout.
Except where stated to the contrary, rats of 180-220g body wt. were used. Animals were fed ad Vol. 219 libitum (Labsure Animal Diet (CRM); C. Hill Group, Poole, Dorset, U.K.).
Reagents
Reagents and radiochemicals were obtained from the sources given previously (Fisher & Pogson, 1984) . The following hormones, agonists and antagonists were obtained from Sigma: phenylephrine, isoprenaline (isoproterenol), adrenaline (epinephrine), noradrenaline (arterenol), propranolol, vasopressin ([arginine] vasopressin; grade VI) and ionophore A23187. Phentolamine was a gift from Ciba Research Laboratories, Horsham, Sussex, U.K. All other chemicals were of the purest grade available from standard suppliers.
Preparation and incubation of hepatocytes Cells were prepared as described previously (Elliott et al., 1976) except that glucose (20mM) was added to the perfusion medium. In all experiments, metabolic integrity was assessed by measurement of ATP content (Dickson & Pogson, 1977) .
Cells were preincubated for 30min with lactate/ pyruvate (9:1, final concn. 1OmM) and glucose (10mM). Incubations (volume 2ml) were as previously described (Smith & Pogson, 1980) . Measurement ofphenylalanine hydroxylation flux L-Phenylalanine was added to a final concentration of 0.05mM and a specific radioactivity of 1.2 x 105 c.p.m./ml. Effectors were added immediately before phenylalanine, except for glucagon, which was added 2min before substrate. All adrenergic agonists and antagonists were prepared immediately before use in Krebs-Henseleit (1932) buffer. A23'187 was prepared (final concn. 250gM) in ethanol. Ethanol on its own had no significant effect on flux through phenylalanine hydroxylase (results not shown). All incubations were terminated with 0.2ml of 2M-HC104.
Flux through both phenylalanine hydroxylase and homogentisate oxidase was assessed by the 3H-release assay described by Fisher & Pogson (1984 Results and discussion Table 1 shows the effect of various agents on the phosphorylation of phenylalanine hydroxylase in incubations of liver cells from adult rats. Control cells under these conditions contain enzyme with approx. 1 molecule of phosphate/tetramer. Glucagon at maximally effective concentrations increases the phosphate content, as previously shown (Fisher & Pogson, 1984) . Neither isoprenaline, a /3-agonist (Levitzki, 1981) , nor vasopressin alters the degree of phosphorylation. Exposure of cells to phenylephrine, an a-agonist (Levitzki, 1981) , however, leads to a 50% increase in enzyme phosphory- (Reed & Lardy, 1972) . Effects on the flux through homogentisate oxidase, further along the catabolic pathway, mirror those on hydroxylase flux, a notunexpected finding in view of the rate-determining role of hydroxylase. The similarity of the effects on phosphorylation of A23187 and the adrenergic agents suggested that the latter might be acting at the a-receptor. The results shown in Table 2 confirm this; the increase in hydroxylation rate with low concentrations of adrenaline or noradrenaline is blocked by the a-antagonist phentolamine, but not by the fiantagonist propranolol.
As noted above, vasopressin (at 0.1 Mm) had no discemible effect on either phosphorylation or phenylalanine hydroxylation. We investigated the possibility that our cells might be 'desensitized' to vasopressin. Parallel measurements showed, however, that both vasopressin and glucagon stimulated glycogen breakdown in incubations of cells from fed animals, whereas glucagon alone increased the extent of hydroxylase phosphorylation (results not shown). Differences between the actions of vasopressin and a-adrenergic agents have been reported (see the introduction).
Some resolution of the discrepancies regarding the 'a' or 'P' mode of action of adrenaline can be achieved on the basis of studies demonstrating that age and sex are important factors; Blair et al. (1979) showed that f-effects occur in young rats, but are lost with growth, and Studer & Borle (1982) found that, although adult females exhibit P responses, adult males do not. (The P-adrenergic response reappears when hepatocytes isolated from adult male rats are maintained in primary culture; Nakamura et al., 1983.) Table 3 details the results of experiments in which flux through the phenylalanine-catabolic pathway was measured in cells from 80g rats. Exposure to isoprenaline increased flux through the hydroxylase, and this was blocked substantially by the P-antagonist, propranolol. In a separate experiment it was shown that neither antagonist on its own affected flux, nor did noradrenaline in the presence of propranolol [control, 4.82 + 0.24; propranolol with regard to phenylalanine hydroxylase (Abita et al., 1980; Hasegawa & Kaufman, 1982) and support the observations made by Blair et al. (1979) . The results of our studies further develop the hypothesis that phenylalanine hydroxylase activity in cells, and, by implication, in vivo, is modulated by protein phosphorylation, and that this phosphorylation may be catalysed by the cyclic AMPdependent protein kinase and a Ca2 +-dependent kinase associated with a-receptors (Exton, 1981 (Exton, , 1982 . Garrison (1983) , in his analysis of two dimensional gel electrophoretograms of hepatic phosphoproteins, noted relatively small effects of vasopressin on phenylalanine hydroxylase, and no effect at all of phorbol esters, which, he proposed, may act by mechanisms related to those of vasopressin and involving protein kinase C (Castagna et al., 1982; Kiss & Mhina, 1982; Niedel et al., 1983) . Our present results are no more than consistent with this postulate, but do suggest that caution should be exercised in the interchangeable use of vasopressin and a-adrenergic agents.
